Eagle Health Investments LP: BIOMARIN PHARMACEUTICALS (BMRN): Quarterly 13F Position History
As of Q1 2026, Eagle Health Investments LP reported 505,809 shares of BIOMARIN PHARMACEUTICALS (BMRN), worth $28.6M and representing 6.0% of its 13F equity book. Quarter-over-quarter share count change: + 138,997 (+37.9%) . The position first appeared in Q2 2024 and has been disclosed across 8 13F-HR filings in Pactolio's tracked window.
- 505,809Shares Held (Latest Filing)
- $28.6MReported Market Value (Latest Filing)
- 6.0%Portfolio Weight (% of 13F Equity Book)
- +138,997Quarter-over-Quarter Share Change
- +$6.8MQuarter-over-Quarter Value Change
- 505,809Peak Reported Shares (Historical)
Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 8 quarter s
| Quarter | Shares | QoQ Share Change | Share Change (%) | Market Value | Weight | Implied Price |
|---|---|---|---|---|---|---|
| Q1 2026 | 505,809 | +138,997 | +37.9% | $28.6M | 6.0% | $56.5 |
| Q4 2025 | 366,812 | 0 | — | $21.8M | 4.8% | $59.4 |
| Q3 2025 | 366,812 | 0 | — | $19.9M | 5.2% | $54.2 |
| Q2 2025 | 366,812 | 15,800 | -4.1% | $20.2M | 5.0% | $55.0 |
| Q1 2025 | 382,612 | 36,600 | -8.7% | $27.0M | 7.0% | $70.7 |
| Q4 2024 | 419,212 | 0 | — | $27.6M | 6.8% | $65.7 |
| Q3 2024 | 419,212 | +187,412 | +80.9% | $29.5M | 5.7% | $70.3 |
| Q2 2024 | 231,800 | — | — | $19.1M | 3.4% | $82.3 |
Methodology & FAQ
How This Position History Is Sourced
Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares — a quarter-end mark, not the manager's cost basis. See the full methodology document for the normalization rules.
When did Eagle Health Investments LP first disclose a BMRN position in 13F-HR filings?
Eagle Health Investments LP first reported BIOMARIN PHARMACEUTICALS (BMRN) on its 13F-HR filing for the period ending 2024-06-30 (Q2 2024). The position has appeared on 8 reported quarters within Pactolio's tracked window.
What was Eagle Health Investments LP's most recent quarter-over-quarter share-count change in BMRN?
Between Q4 2025 and Q1 2026, Eagle Health Investments LP added 138,997 shares of BMRN (+37.9%), bringing the total reported position to 505,809 shares at a market value of $28.6M.
Does the implied price-per-share represent Eagle Health Investments LP's cost basis in BMRN?
No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.